Category:Peptide suppliers

Category·28 pages·2 subcategories

Organisations that manufacture or distribute research peptides and related material.

Category tree: PeptidePedia Wiki contents › Quality and testing › Peptide suppliers

Subcategories

This category has 2 subcategories.

Contract manufacturers (4)
Suppliers in China (28)

Pages in this category

The following 28 pages are in this category.

Supplier directory

The organisations below meet Project:Vendor notability and have an article each. The article is the neutral account; the official site is the organisation's own catalogue and is the place to check a listing, a stock position or a stated dispatch window.

Organisations with an article on PeptidePedia Wiki
Organisation	Trading name	Registered city	Article	Official site
AmbioPharm, Inc.	AMB	Beijing	AmbioPharm (talk)	Visit AMB →
Asymchem Laboratories (Tianjin) Co., Ltd.	ASY	Tianjin	Asymchem Laboratories (talk)	Visit ASY →
Bachem Holding (Suzhou) Co., Ltd.	BCH	Suzhou	Bachem Holding (Suzhou) (talk)	Visit BCH →
ChinaPeptides Co., Ltd. (QYAOBIO)	QYB	Shanghai	ChinaPeptides (talk)	Visit QYB →
Chinese Peptide Company Co., Ltd.	CPC	Hangzhou	Chinese Peptide Company (talk)	Visit CPC →
Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.	FGP	Chengdu	Flourishglobal Peptide Biotech (talk)	Visit FGP →
GenScript Biotech Corporation	GSP	Nanjing	GenScript Peptides (talk)	Visit GSP →
GL Biochem (Shanghai) Ltd.	GL Biochem	Shanghai	GL Biochem (Shanghai) (talk)	Visit GL Biochem →
Guangzhou JEEP Biotechnology Co., Ltd.	JEEP	Guangzhou	Guangzhou JEEP Biotechnology (talk)	Visit JEEP →
Hubei Jianxiang Bioscience Co., Ltd.	HJ	Xianning	Hubei Jianxiang Bioscience (talk)	Visit HJ →
Hunan Aslsen Technology Co., Ltd.	Homopeptide	Changsha	Hunan Aslsen Technology (talk)	Visit Homopeptide →
Nantong Guangyuan Chemical Co., Ltd.	GGPeps	Nantong	Nantong Guangyuan Chemical (talk)	Visit GGPeps →
PolyPeptide Group (Hangzhou) Co., Ltd.	PPG	Hangzhou	PolyPeptide Group (Hangzhou) (talk)	Visit PPG →
Qingdao Saber Technology Pharmaceutical	QST	Qingdao	Qingdao Saber Technology Pharmaceutical (talk)	Visit QST →
Qingdao Sigma Chemical Co., Ltd.	QSC	Qingdao	Qingdao Sigma Chemical (talk)	Visit QSC →
Sangon Biotech (Shanghai) Co., Ltd.	SGN	Shanghai	Sangon Biotech (talk)	Visit SGN →
Shanghai ERP Biotechnology Co., Ltd.	ERP	Shanghai	Shanghai ERP Biotechnology (talk)	Visit ERP →
Shanghai Sigma-Audley New Material Technology Co., Ltd.	SSA	Shanghai	Shanghai Sigma-Audley New Material Technology (talk)	Visit SSA →
Shanghai Wibson Biotechnology Co., Ltd.	SWB	Shanghai	Shanghai Wibson Biotechnology (talk)	Visit SWB →
Shenzhen Hybio Pharmaceutical Co., Ltd.	HYB	Shenzhen	Shenzhen Hybio Pharmaceutical (talk)	Visit HYB →
Sigma-Aldrich (Shanghai) Trading Co., Ltd.	SIG	Shanghai	Sigma-Aldrich (Shanghai) Trading (talk)	Visit SIG →
SinoPep Biotechnology (Changzhou) Co., Ltd.	SinoPep	Changzhou	SinoPep (talk)	Visit SinoPep →
Thermo Fisher Scientific (China) Co., Ltd.	TFS	Shanghai	Thermo Fisher Scientific (China) (talk)	Visit TFS →
Tianjin Finder Chemical Co., Ltd.	TFC	Tianjin	Tianjin Finder Chemical (talk)	Visit TFC →
Wuhan Wansheng Biotechnology Co., Ltd.	WWB	Wuhan	Wuhan Wansheng Biotechnology (talk)	Visit WWB →
WuXi TIDES (WuXi AppTec Testing Division)	WXT	Wuxi	WuXi TIDES (talk)	Visit WXT →
Xi'an Mokemei Biotechnology Co., Ltd.	MKM	Xi'an	Xi'an Mokemei Biotechnology (talk)	Visit MKM →
Zhuhai Kerui Biotechnology Co., Ltd.	KP	Zhuhai	Zhuhai Kerui Biotechnology (talk)	Visit KP →

Outbound links are marked nofollow and sponsored. PeptidePedia sells nothing, takes no commission and publishes no ranking; the order of this table is the order of the article titles.

Organisations without an article

The following 188 organisations are named in the sources this encyclopedia draws on but do not meet Project:Vendor notability: there is not enough independent, published material about them to write a neutral article. They are listed here for completeness. No article, no assessment, no external link.

Organisation	Reports seen	Why no article
Trusted Peptide	2	2 reports, all from purchasers who chose to submit. Self-selection at that scale cannot be corrected for. Neither an incorporation year nor a location is documented anywhere available here.
Risynth Bio	8	Band B, 8 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. The supplier's own material is the only description of its operations available.
NUPEPS Peptides	4	4 reports recorded. With a sample this small a single unrepresentative vial moves the picture entirely. No registry record has been matched to the trading name used here.
Hunan GoodPeptides Biotech Co	2	Coverage amounts to 2 reports, with no indication of how many catalogue lines they were drawn from. No registry record has been matched to the trading name used here.
Bulk Peptide Wholesale	20	Band B across 20 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No analytical conditions accompany any result on file.
Paradigm Peptide	16	Band B across 16 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No registry record has been matched to the trading name used here.
Orbitrex Peptides	17	Band B across 17 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. No analytical conditions accompany any result on file.
Aavant Research	13	Band B across 13 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No registry record has been matched to the trading name used here.
PeptiAtlas	4	4 reports, all from purchasers who chose to submit. Self-selection at that scale cannot be corrected for. No registry record has been matched to the trading name used here.
The Naughty Needle	2	The whole documented record is 2 reports. A run of that length would look identical whether the process behind it were controlled or not. Listing here records the absence of usable sources and nothing else.
Lux Synth Aminos	2	2 reports on file. That is an anecdote about a shipment, not a record of a supplier, and no neutral article can be written from it. The entry would become an article the moment independent material appeared.
Huaian Hanyou Peptide	7	Band B across 7 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself.
Lisa Biopeptide	11	Band B across 11 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. The supplier's own material is the only description of its operations available.
Lipeptides	7	Band B across 7 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No independent coverage exists in any source unconnected with the supplier or its purchasers.
NextGen Health	3	3 reports on file. That is an anecdote about a shipment, not a record of a supplier, and no neutral article can be written from it. Nothing in the file has been contradicted; there is simply too little of it.
OmegAmino	4	Documented testing is 4 reports. Nothing in the file establishes whether those results are typical. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Xianhong Tong XHT Peptides	5	Band B across 5 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. Listing here records the absence of usable sources and nothing else.
Diju Peptides Wellness and Co	4	The record extends to 4 reports and to no independent source of any other kind. No analytical conditions accompany any result on file.
Zhang TY	4	Documented testing is 4 reports. Nothing in the file establishes whether those results are typical. The supplier's own material is the only description of its operations available.
SubQ Society	3	Documented testing is 3 reports. Nothing in the file establishes whether those results are typical. No registry record has been matched to the trading name used here.
Bfflink	13	13 reports at band B. No certificate examined carries both a purity and a content determination, so the reported figures cannot be converted into a mass.
Laicuinuo LCN	7	Placed at band B on 7 reports. The documentary base is the reports and the supplier's own pages, and the second is usable only for what it states about itself. No analytical conditions accompany any result on file.
Cellupep	7	Band B across 7 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. Listing here records the absence of usable sources and nothing else.
Shanghai Leader Peptide Biotechnology	8	8 reports at band B. No certificate examined carries both a purity and a content determination, so the reported figures cannot be converted into a mass. The supplier's own material is the only description of its operations available.
Peptronix Bio PTB	13	Band B across 13 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Yongkang Nuoao Trading Co	9	Band B across 9 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No analytical conditions accompany any result on file.
Eros Peptides	3	3 reports recorded. With a sample this small a single unrepresentative vial moves the picture entirely. The supplier's own material is the only description of its operations available.
Champion Peptide	6	6 reports at band B. Consistency across a self-selected set is weak evidence of consistency in anything else. Nothing in the file has been contradicted; there is simply too little of it.
Bio Pepz	4	The whole documented record is 4 reports. A run of that length would look identical whether the process behind it were controlled or not. Listing here records the absence of usable sources and nothing else.
Shandong Nuoweiou Medical Technology Co	5	Band B, 5 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. Listing here records the absence of usable sources and nothing else.
PurePEPS	4	Coverage stands at 4 reports. A handful of results describes the vials tested and cannot describe the process that produced them. No analytical conditions accompany any result on file.
Rayshine Peptide Biochemicals	6	Band C across 6 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. No independent coverage exists in any source unconnected with the supplier or its purchasers.
HealthTide Biotech	6	6 reports at band C. Consistency across a self-selected set is weak evidence of consistency in anything else. No analytical conditions accompany any result on file.
Dankang BioHealth	12	Band C, 12 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. Coverage does not extend to a second lot of any single line.
Kits4less	7	Band C across 7 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. Neither an incorporation year nor a location is documented anywhere available here.
Huayi Biotechnology	19	Band C across 19 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. No registry record has been matched to the trading name used here.
Anlv Biotechnology	10	10 reports at band C. Consistency across a self-selected set is weak evidence of consistency in anything else. The supplier's own material is the only description of its operations available.
Xingtai Pukelai Technology Co	6	Band C across 6 reports. The results are internally consistent; what is missing is any source about the organisation that is not a purchaser or the organisation itself. No analytical conditions accompany any result on file.
EHZ Peptides	39	39 reports at band C. Consistency across a self-selected set is weak evidence of consistency in anything else. No registry record has been matched to the trading name used here.
Zztai Peptide	30	Band C, 30 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. No registry record has been matched to the trading name used here.
Chimera Peptides	8	Band C across 8 reports, none of which states the analytical conditions. The figures agree; whether they are measuring the same thing is not established. Nothing in the file has been contradicted; there is simply too little of it.
Hangzhou Mandy Biotechnology	14	Band C, 14 reports. Coverage does not extend across the catalogue, and nothing indicates which lines the reports were drawn from. No registry record has been matched to the trading name used here.
Yabang Peptide	10	Band C, 10 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. Neither an incorporation year nor a location is documented anywhere available here.
Evolve BioPep	7	7 reports at band C. No certificate examined carries both a purity and a content determination, so the reported figures cannot be converted into a mass. The supplier's own material is the only description of its operations available.
Quenna PMQ	15	15 reports at band D. Nothing on file describes the analytical method, so the figures cannot be compared with figures obtained elsewhere. The supplier's own material is the only description of its operations available.
Nanjing Xiyuxun Technology XYX	3	3 reports on file. That is an anecdote about a shipment, not a record of a supplier, and no neutral article can be written from it. No analytical conditions accompany any result on file.
Welon Peptide Solutions	5	Placed at band D on 5 reports. The record is settled enough to place and thin enough that placing it is most of what can be said. The entry would become an article the moment independent material appeared.
Xingtai Lesda Technology	6	Band E on 6 reports, with no material available beyond the reports themselves and the supplier's own listings. No analytical conditions accompany any result on file.
Qingdao Hongshengda Trading	4	Documented testing is 4 reports. Nothing in the file establishes whether those results are typical. Coverage does not extend to a second lot of any single line.
ZZQ Peptides	22	Band E across 22 reports. No independent source unconnected with the supplier or its purchasers is available. Listing here records the absence of usable sources and nothing else.
Changan District Sheng Peptide Trading	7	Band E on 7 reports, with no material available beyond the reports themselves and the supplier's own listings. No registry record has been matched to the trading name used here.
UWA Elite Peptides	16	16 reports at band E. Nothing on file describes the analytical method, so the figures cannot be compared with figures obtained elsewhere. Nothing in the file has been contradicted; there is simply too little of it.
Hangzhou Youngpeptide Biotechnology HYB	15	Band E on 15 reports, with no material available beyond the reports themselves and the supplier's own listings. The supplier's own material is the only description of its operations available.
Modern Aminos	4	Documented testing is 4 reports. Nothing in the file establishes whether those results are typical. The entry would become an article the moment independent material appeared.
Shanghai OuDaXin New Material Technology Center	43	Placed at band E on 43 reports. The record is settled enough to place and thin enough that placing it is most of what can be said. No analytical conditions accompany any result on file.
Shenzhen Jiechuang Trading	8	Band E on 8 reports, with no material available beyond the reports themselves and the supplier's own listings. No registry record has been matched to the trading name used here.
Shaanxi Dideu Medichem	6	6 reports at band E. Nothing on file describes the analytical method, so the figures cannot be compared with figures obtained elsewhere. The supplier's own material is the only description of its operations available.
Qingdao VitaConin International Trading	5	Band E on 5 reports, with no material available beyond the reports themselves and the supplier's own listings. No method statement accompanies any result on file.
Guangzhou Lengiuanhuang Cosmetics	4	The whole documented record is 4 reports. A run of that length would look identical whether the process behind it were controlled or not. Nothing in the file has been contradicted; there is simply too little of it.
Shanghai JinBei Chemical Technology	18	18 reports at band B. Consistency across a self-selected set is weak evidence of consistency in anything else. Listing here records the absence of usable sources and nothing else.
Peptide Technologies	11	Placed at band B on 11 reports. The documentary base is the reports and the supplier's own pages, and the second is usable only for what it states about itself. No analytical conditions accompany any result on file.
Pura Peptides	1	Unbanded. One report exist; none carries the method statement that would make the figures comparable with each other. No analytical conditions accompany any result on file.
Peptide Partners	64	Across 64 reports the reported band moves between B and C. Nothing on file accounts for the movement. The supplier's own material is the only description of its operations available.
Bfflist AMO	63	Results on file fall across bands B to C. Averaging a spread like that would produce a figure describing nothing that was actually measured. The entry would become an article the moment independent material appeared.
Pure Tested Peptides	7	The submitted results cover bands B to C. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. No method statement accompanies any result on file.
PeptiSlim	38	The submitted results cover bands C to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. Coverage does not extend to a second lot of any single line.
Glamgurcraft Innovations Foreign Trade	1	No grade is recorded. The available material describes results without describing the determinations behind them, which is the condition this list exists to record. No independent coverage exists in any source unconnected with the supplier or its purchasers.
HkRoids	14	14 reports distributed across bands B to C. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. Neither an incorporation year nor a location is documented anywhere available here.
Yiwu Aozuo Trading Co	91	Coverage is 91 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Peptide Haven	4	4 reports, all from purchasers who chose to submit. Self-selection at that scale cannot be corrected for.
Atomik Labz	40	The submitted results cover bands B to C. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. The supplier's own material is the only description of its operations available.
Bulk Peptide Supply	20	Across 20 reports the reported band moves between B and E. Nothing on file accounts for the movement. No method statement accompanies any result on file.
M-Peptides	17	Coverage is 17 reports and the results run from B to C. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Neither an incorporation year nor a location is documented anywhere available here.
Mai Peptide	55	55 reports distributed across bands C to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No registry record has been matched to the trading name used here.
Peptidology	16	16 reports at band B. Consistency across a self-selected set is weak evidence of consistency in anything else.
Hazel	1	No grade is recorded. The available material describes results without describing the determinations behind them, which is the condition this list exists to record. No analytical conditions accompany any result on file.
TCI	1	Unbanded. One report exist; none carries the method statement that would make the figures comparable with each other. Neither an incorporation year nor a location is documented anywhere available here.
Uther	69	Across 69 reports the reported band moves between B and E. Nothing on file accounts for the movement. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Shandong Shengyuan Peptide Technology	24	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. No registry record has been matched to the trading name used here.
LiliPeptide	185	Results on file fall across bands C to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Xingruida XDR	64	Coverage is 64 reports and the results run from B to D. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No method statement accompanies any result on file.
Eternal Peptides	23	Placed at band B on 23 reports. The documentary base is the reports and the supplier's own pages, and the second is usable only for what it states about itself. The entry would become an article the moment independent material appeared.
Tianjin Ruiwang New Material Technology Co	107	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. Listing here records the absence of usable sources and nothing else.
Polaris Peptides	97	Coverage is 97 reports and the results run from B to D. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Listing here records the absence of usable sources and nothing else.
Injectify	29	The submitted results cover bands B to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. No method statement accompanies any result on file.
Precision Peptide Co	21	Reported results span bands B to C, across 21 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. No analytical conditions accompany any result on file.
AKS Chem	1	No band. One report are on record and the documentation accompanying them does not stand on its own. No method statement accompanies any result on file.
Reta-Peptide	144	Coverage is 144 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Listing here records the absence of usable sources and nothing else.
Peptide-S	125	Coverage is 125 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Nothing in the file has been contradicted; there is simply too little of it.
Planet Peptide	59	The submitted results cover bands B to D. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. No method statement accompanies any result on file.
Henan Sahe Peptide	18	Results on file fall across bands B to D. Averaging a spread like that would produce a figure describing nothing that was actually measured. The entry would become an article the moment independent material appeared.
Hunan Ruiwang Technology Center	14	Across 14 reports the reported band moves between B and C. Nothing on file accounts for the movement. No registry record has been matched to the trading name used here.
Skye Peptides	73	Coverage is 73 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Listing here records the absence of usable sources and nothing else.
Nuscience Peptides	47	Across 47 reports the reported band moves between B and D. Nothing on file accounts for the movement. No method statement accompanies any result on file.
NextechLabs	30	Reported results span bands B to D, across 30 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence.
Golden Eagle	17	Coverage is 17 reports and the results run from B to C. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here.
Peptide Worldwide	1	Unbanded on one report. Where a report does not state how a figure was obtained, it cannot be set against a figure obtained some other way.
HK Peptides	343	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. No method statement accompanies any result on file.
Nexaph	200	The submitted results cover bands B to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. Nothing in the file has been contradicted; there is simply too little of it.
BeiBangAn	38	38 reports distributed across bands C to D. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Shandong Aishi Biotechnology	37	Coverage is 37 reports and the results run from D to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Xingtai Jiachuang Technology	31	Results range across bands C to E on 31 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Neither an incorporation year nor a location is documented anywhere available here.
Zenith Jove Peptide ZJ	26	26 reports spanning bands B to E. A wider spread than the reports themselves can explain. No analytical conditions accompany any result on file.
Kerisite Shenzhen International	16	Results range across bands B to D on 16 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Neither an incorporation year nor a location is documented anywhere available here.
YB Peptide	10	10 reports spanning bands B to E. A wider spread than the reports themselves can explain. No method statement accompanies any result on file.
Qing Li Peptide	260	260 reports spanning bands B to E. A wider spread than the reports themselves can explain. No registry record has been matched to the trading name used here.
Shanxi Qianyecao Biotech QYC	66	Coverage is 66 reports and the results run from D to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Verified Peptides	34	34 reports spanning bands B to C. A wider spread than the reports themselves can explain. No method statement accompanies any result on file.
Hebei Rimao Technology	32	32 reports distributed across bands C to D. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. The supplier's own material is the only description of its operations available.
Pure Rawz	29	Results on file fall across bands B to D. Averaging a spread like that would produce a figure describing nothing that was actually measured.
Heman Peptide HM	29	29 reports spanning bands B to E. A wider spread than the reports themselves can explain. Neither an incorporation year nor a location is documented anywhere available here.
Shanghai Baoju	21	21 reports spanning bands B to E. A wider spread than the reports themselves can explain. Neither an incorporation year nor a location is documented anywhere available here.
ZLZ Peptide	199	199 reports distributed across bands B to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Peptide Sciences	123	Results range across bands B to E on 123 reports. No documentation accompanying them distinguishes a variable process from variable measurement. The entry would become an article the moment independent material appeared.
Allen Biotechnology Co ABC	43	The submitted results cover bands B to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Peptide Crafters	39	Reported results span bands B to D, across 39 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Neither an incorporation year nor a location is documented anywhere available here.
Simple Peptide	26	The submitted results cover bands B to D. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. Nothing in the file has been contradicted; there is simply too little of it.
Top Peptide	21	21 reports distributed across bands C to D. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No analytical conditions accompany any result on file.
Zen Peptides	13	Results on file fall across bands B to C. Averaging a spread like that would produce a figure describing nothing that was actually measured. No registry record has been matched to the trading name used here.
Amino Lair	12	Results on file fall across bands B to D. Averaging a spread like that would produce a figure describing nothing that was actually measured. No registry record has been matched to the trading name used here.
Oupeptide	149	149 reports distributed across bands B to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No analytical conditions accompany any result on file.
Paramount Peptides	65	Across 65 reports the reported band moves between B and E. Nothing on file accounts for the movement. The supplier's own material is the only description of its operations available.
Yimei	54	Reported results span bands B to E, across 54 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Listing here records the absence of usable sources and nothing else.
LSPL	40	Coverage is 40 reports and the results run from C to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No registry record has been matched to the trading name used here.
Royal Peptides	30	30 reports spanning bands B to C. A wider spread than the reports themselves can explain. Nothing in the file has been contradicted; there is simply too little of it.
Shenzhen Loga Tech LG LOGA	21	21 reports spanning bands B to E. A wider spread than the reports themselves can explain. Nothing in the file has been contradicted; there is simply too little of it.
ZhuoYan lab	30	Across 30 reports the reported band moves between C and E. Nothing on file accounts for the movement. No analytical conditions accompany any result on file.
Astro Peptides	29	Reported results span bands B to E, across 29 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Neither an incorporation year nor a location is documented anywhere available here.
Mix Peptides	29	Results on file fall across bands D to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. Neither an incorporation year nor a location is documented anywhere available here.
Science	12	Across 12 reports the reported band moves between B and C. Nothing on file accounts for the movement. Nothing in the file has been contradicted; there is simply too little of it.
TSC Top Supplements China	99	Reported results span bands C to E, across 99 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Coverage does not extend to a second lot of any single line.
HXNet	91	Coverage is 91 reports and the results run from C to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here.
Xian Yihang Technology	48	Reported results span bands C to E, across 48 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Neither an incorporation year nor a location is documented anywhere available here.
Haikou Mingheng Technology	16	Results range across bands B to C on 16 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Listing here records the absence of usable sources and nothing else.
SRY Labs	111	Results range across bands B to E on 111 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Listing here records the absence of usable sources and nothing else.
Accelerate Labs	20	The submitted results cover bands B to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which.
PurePeptides	15	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Regenerative Research	2	No grade is recorded. The available material describes results without describing the determinations behind them, which is the condition this list exists to record. Coverage does not extend to a second lot of any single line.
Zhejiang Yichenkang Biotechnology	58	58 reports distributed across bands B to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No analytical conditions accompany any result on file.
Biolongevity Labs	33	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. No analytical conditions accompany any result on file.
Alpha-Gen	30	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. The entry would become an article the moment independent material appeared.
LN Peptides	28	Coverage is 28 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No method statement accompanies any result on file.
Forever Young Pharmacy	26	26 reports distributed across bands B to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Prime Peptides	19	19 reports distributed across bands B to E. Two purchasers reading this entry would be entitled to opposite expectations, which is exactly why no article exists. Neither an incorporation year nor a location is documented anywhere available here.
Haikou Mingheng Biotechnology	11	Reported results span bands D to E, across 11 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Neither an incorporation year nor a location is documented anywhere available here.
Dragon Pharma	1	No band assigned, on one report. The results are not disputed; they are simply not documented well enough to be placed. No registry record has been matched to the trading name used here.
Liberty Peptides	16	Reported results span bands B to E, across 16 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Listing here records the absence of usable sources and nothing else.
Amino Asylum	15	Across 15 reports the reported band moves between B and C. Nothing on file accounts for the movement. The supplier's own material is the only description of its operations available.
Amino Amigos	37	Across 37 reports the reported band moves between B and E. Nothing on file accounts for the movement. No registry record has been matched to the trading name used here.
Platinum Cryo	24	Coverage is 24 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Elite Research USA	47	Results range across bands B to E on 47 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Coverage does not extend to a second lot of any single line.
Limitless Life Nootropics	22	Across 22 reports the reported band moves between B and D. Nothing on file accounts for the movement. No registry record has been matched to the trading name used here.
Oasis Peptides	16	Results on file fall across bands B to E. Averaging a spread like that would produce a figure describing nothing that was actually measured. The supplier's own material is the only description of its operations available.
Suaway Lab Research	39	39 reports spanning bands B to E. A wider spread than the reports themselves can explain. Nothing in the file has been contradicted; there is simply too little of it.
Pharma Grade Peptides	18	The submitted results cover bands B to E. Dispersion of that size is either lot-to-lot variation or method variation between reporters, and the file does not say which. The entry would become an article the moment independent material appeared.
PeptiLab Research	15	Results range across bands B to E on 15 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Neither an incorporation year nor a location is documented anywhere available here.
Tydes	41	Results range across bands C to E on 41 reports. No documentation accompanying them distinguishes a variable process from variable measurement. No analytical conditions accompany any result on file.
Loti Labs	32	Coverage is 32 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here.
Wolverine Peptides	1	No band has been assigned. The one report on file are not accompanied by documentation that would let one be, and an unsupported grade is worse than none. The supplier's own material is the only description of its operations available.
Amplified Amino	12	Across 12 reports the reported band moves between C and E. Nothing on file accounts for the movement. The supplier's own material is the only description of its operations available.
Alimo Peptide	7	Coverage is 7 reports and the results run from D to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. Nothing in the file has been contradicted; there is simply too little of it.
Richards Biotech Simply Richards	1	No band. One report are on record and the documentation accompanying them does not stand on its own. Nothing in the file has been contradicted; there is simply too little of it.
Coastal Peptides	26	Reported results span bands B to E, across 26 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Listing here records the absence of usable sources and nothing else.
Peptides 4 Research	20	20 reports spanning bands C to E. A wider spread than the reports themselves can explain. Nothing in the file has been contradicted; there is simply too little of it.
Deuschem	29	Coverage is 29 reports and the results run from B to E. The entry records the range rather than a summary of it, because a summary would conceal the only informative fact here. No method statement accompanies any result on file.
Hybiopeptides	1	No grade is recorded. The available material describes results without describing the determinations behind them, which is the condition this list exists to record. The supplier's own material is the only description of its operations available.
Peptide Gurus	45	Results range across bands B to E on 45 reports. No documentation accompanying them distinguishes a variable process from variable measurement. Listing here records the absence of usable sources and nothing else.
Swiss Chems	9	Reported results span bands C to E, across 9 reports. A range that wide is not a supplier characteristic that can be summarised in a sentence. Coverage does not extend to a second lot of any single line.
WllyBIO	1	Unbanded on one report. Where a report does not state how a figure was obtained, it cannot be set against a figure obtained some other way. No analytical conditions accompany any result on file.
Biolabshop Limited	6	6 reports spanning bands C to E. A wider spread than the reports themselves can explain. Coverage does not extend to a second lot of any single line.
Peptides For Sale	21	21 reports spanning bands D to E. A wider spread than the reports themselves can explain. The supplier's own material is the only description of its operations available.
NuLife Peptides	6	Band B, 6 reports. Nothing establishes incorporation, location or operating history, so an organisation article would have an identity section with nothing in it. No registry record has been matched to the trading name used here.
Wuhan Newtop Biotech	2	No band assigned, on 2 reports. The results are not disputed; they are simply not documented well enough to be placed. Neither an incorporation year nor a location is documented anywhere available here.
LOOKBiotech	2	Unbanded. 2 reports exist; none carries the method statement that would make the figures comparable with each other. Nothing in the file has been contradicted; there is simply too little of it.
PRIVATE	2	No band. 2 reports are on record and the documentation accompanying them does not stand on its own. The supplier's own material is the only description of its operations available.
Peptide Ark	2	Unbanded on 2 reports. Where a report does not state how a figure was obtained, it cannot be set against a figure obtained some other way. Neither an incorporation year nor a location is documented anywhere available here.
Zhuoyue Biotechnology	1	No band assigned, on one report. The results are not disputed; they are simply not documented well enough to be placed. Coverage does not extend to a second lot of any single line.
Hebei Chengtong Technology	1	Unbanded on one report. Where a report does not state how a figure was obtained, it cannot be set against a figure obtained some other way. Listing here records the absence of usable sources and nothing else.
Coffee and Peppers	1	No band. One report are on record and the documentation accompanying them does not stand on its own.
Marvel Peptide	1	Unbanded on one report. Where a report does not state how a figure was obtained, it cannot be set against a figure obtained some other way. Nothing in the file has been contradicted; there is simply too little of it.
HK Fat Cat	1	Unbanded. The file holds a single report, with no analytical conditions stated for it. The entry would become an article the moment independent material appeared.
Guangzhou Yuao Trading	1	Unbanded. The file holds a single report, with no analytical conditions stated for it. Nothing in the file has been contradicted; there is simply too little of it.
PepKits	1	No band has been assigned. The one report on file are not accompanied by documentation that would let one be, and an unsupported grade is worse than none.
Lejian Biotech Peptide	1	No band has been assigned. The one report on file are not accompanied by documentation that would let one be, and an unsupported grade is worse than none. Listing here records the absence of usable sources and nothing else.
PepLab Solutions	1	No band has been assigned. The one report on file are not accompanied by documentation that would let one be, and an unsupported grade is worse than none. No independent coverage exists in any source unconnected with the supplier or its purchasers.
Explicit Sarms	1	No band assigned, on one report. The results are not disputed; they are simply not documented well enough to be placed. Nothing in the file has been contradicted; there is simply too little of it.
Weifang Xingbei International Trade	1	Unbanded. One report exist; none carries the method statement that would make the figures comparable with each other. Coverage does not extend to a second lot of any single line.
Advanced Technology and Industrial	1	No band assigned, on one report. The results are not disputed; they are simply not documented well enough to be placed. No independent coverage exists in any source unconnected with the supplier or its purchasers.

Listing here records the absence of usable sources, not a judgement about the organisation. Any of these would qualify for an article if independent coverage appeared.